Radioimmunoassay for chlorpromazine in plasma

Area of Science:

• Pharmacology
• Analytical Chemistry
• Clinical Chemistry

Background:

• Accurate quantification of chlorpromazine in biological samples is crucial for therapeutic drug monitoring.
• Existing methods may lack specificity or sensitivity for detecting chlorpromazine and its active metabolites.

Purpose of the Study:

• To develop and validate a specific and sensitive radioimmunoassay (RIA) for quantifying chlorpromazine in human plasma.
• To assess the RIA's ability to detect chlorpromazine and its active metabolite, N-desmethylchlorpromazine.

Main Methods:

• Development of a specific antiserum by immunizing rabbits with a conjugate of bovine serum albumin and N-(2-carboxyethyl)desmethylchlorpromazine.
• Validation of the RIA for specificity against known metabolites and other psychotropic drugs.
• Determination of assay sensitivity and sample throughput.

Main Results:

• The RIA demonstrated high specificity for chlorpromazine and N-desmethylchlorpromazine, with no cross-reactivity from other tested compounds.
• The assay could detect less than 34 pg of chlorpromazine in 200 muL of plasma.
• A single technician could process up to 100 samples per day.

Conclusions:

• The developed radioimmunoassay provides a sensitive, specific, and efficient method for measuring chlorpromazine and N-desmethylchlorpromazine in plasma.
• This assay facilitates pharmacokinetic studies and therapeutic drug monitoring of chlorpromazine.